S. Özkan and D. Gezer, “The impact of dapagliflozin on FIB-4 index over 2 years in patients with type 2 diabetes mellitus”, Eur Res J, vol. 11, no. 4, pp. 676–682, Jul. 2025, doi: 10.18621/eurj.1631079.